For others, particularly those with significant obesity-related health conditions, the potential benefits of earlier access justify the additional risks of the research market
Nature Reviews Endocrinology , 17(7), 391-405
Many plans now cover GLP-1 medications for weight management, particularly for patients with obesity-related comorbidities
But unfortunately, it's not always something that all doctors think about
If your body has a challenging time breaking down food, add a clinically backed enzyme blend to your meals to help you process your food, absorb nutrients faster and ultimately help you eliminate what your body doesn't need
Some healthcare providers may recommend combining SGLT2 inhibitors with other medications to get similar weight loss results to GLP-1s